Jill Carroll

Jill Carroll (finance chief) discloses dealings in 2 companies, chiefly Arcellx, Inc. and Avalyn Pharma Inc. We count 9 filings; the first trade dates from 8 February 2022 and the latest from 1 May 2026.

On the open market, the record shows 1 purchase worth €4.3M and 4 sales worth €93.6M. The net balance comes to €89.3M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2026: 1 purchase and no sales on the market.

On 1 May 2026 came the latest disclosure, an open-market purchase for €4.3M in Avalyn Pharma Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.